Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
AFN-1252
.
Show all posts
Showing posts with label
AFN-1252
.
Show all posts
Monday, April 8, 2013
Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI
›
We know that, AFN-1252, is a selective inhibitor of Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI), which is involved ...
›
Home
View web version
